Short answer
Moderna (MRNA) filed an 8-K current report with the SEC on September 30, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Juan Andres appointed COO effective October 5, 2026, reporting to CEO Stephane Bancel and joining the Executive Committee.
Moderna 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Juan Andres appointed COO effective October 5, 2026, reporting to CEO Stephane Bancel and joining the Executive Committee
- Newly created role addresses Moderna’s increasing scale and diversification
- Andres brings prior experience scaling Moderna’s global manufacturing network and COVID-19 vaccine production
- Compensation includes $800,000 base salary, 90% annual bonus target, and $5,000,000 equity grant vesting over four years
- Chief Technical Operations and Quality Officer Jerh Collins will retire, creating leadership transition risk in manufacturing and quality operations
Item 7.01 · Regulation FD Disclosure
- Andres appointed Chief Operating Officer, signaling a leadership change in Moderna’s operational organization
- Press release furnished as Exhibit 99.1, with appointment details available there
- COO transition may affect execution priorities and operational oversight
Item EX-99.1 · Exhibit EX-99.1
- New COO role signals operational scaling for oncology expansion and five-vaccine infectious-disease franchise
- Juan Andres returns October 5, 2026, leading manufacturing and execution across the Company
- Jerh Collins’ retirement creates technical-operations leadership transition after four years at Moderna
- Leadership change tied to potential launch and scale-up of intismeran autogene, jointly developed with Merck
- Intismeran autogene launch remains uncertain, with forward-looking statements subject to clinical and commercial risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Moderna 8-K filings
Get the next MRNA 8-K as it lands
Follow MRNA for push alerts, or ask the research agent what this filing means.